| Brand Name | Cimzia |
| Generic Name | Certolizumab Pegol |
| Drug Class | Tumor Necrosis Factor (TNF) Blocker |
| Availability | Prescription |
| Manufacturer | UCB Pharma |
| Indications | Rheumatoid arthritis, Crohn's disease, Psoriatic arthritis |
| Type | Injection |
| Doses | 200-400 mg every 2-4 weeks |
| Route | Subcutaneous |
| Side Effects | Injection site reactions, fatigue, infections |
| Interactions | Biologics, immunosuppressants |
| Overdose | Seek emergency help for serious infections |
| Missed Dose | Administer as soon as possible, do not double dose |
| Contraindications | Active infections, tuberculosis |
| Alternatives | Humira, Enbrel |
| Co-Pay Assistance Program | Available |
| Patient Assistance Program | Available |
Dr. Bharat Pothuri is a Board-Certified Gastroenterologist and Hepatologist. With extensive experience in digestive health, he specializes in advanced endoscopic procedures, chronic GI disorder management, and preventive care. Dr. Pothuri is dedicated to providing expert, patient-focused insights to help improve gut health and overall well-being.
Treats inflammatory autoimmune conditions.
Subcutaneous injection every 2-4 weeks.
Yes, monitor closely for infections.
It may be used; consult your doctor.
Increased infection and rare malignancies.
